CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3031% below fair value

$89.79+0.27 (+0.30%)

Close on Nov 12, 2026Market cap $114.84BP/E 10.5Yield 2.96%

Cvs Health EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cvs Health's EV/EBITDA was 12.7× on Nov 11, 2026, against 16.4× a year earlier. Over the last 5 years it ranged from 7.1× to 17.5×, with a median of 10.6×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	12.7×	−3.7
2025	Dec 31, 2025	16.3×	+8.4
2024	Dec 31, 2024	8.0×	−0.1
2023	Dec 29, 2023	8.0×	−6.1
2022	Dec 30, 2022	14.2×	+4.1
2021	Dec 31, 2021	10.1×	+2.4
2020	Dec 31, 2020	7.7×	−3.8
2019	Dec 31, 2019	11.4×	+1.5
2018	Dec 31, 2018	9.9×	+1.8
2017	Dec 29, 2017	8.1×	+1.5
2016	Dec 30, 2016	6.6×	−5.5
2015	Dec 31, 2015	12.0×	+1.6
2014	Dec 31, 2014	10.4×	+1.0
2013	Dec 31, 2013	9.5×	+1.4
2012	Dec 31, 2012	8.1×	−0.1
2011	Dec 30, 2011	8.1×	+0.7
2010	Dec 31, 2010	7.4×	+0.1
2009	Dec 31, 2009	7.4×	–